Struggling with Atopic Dermatitis (Eczema)?

Do you suffer from dry, itchy skin?

Atopic dermatitis, also known as eczema, is a chronic inflammatory skin condition that causes redness, dryness, and irritation. It’s often treated with moisturizers and topical steroids, while more severe cases may require systemic medications that come with potential side effects.

If you’ve been diagnosed with moderate to severe atopic dermatitis, you may qualify for a research study testing two investigational medications that may help improve symptoms and lead to clearer skin.

The study is available at select locations across the U.S. If you qualify, all study-related care will be provided at no cost, and you may be reimbursed for your time and travel.

About the Study

This clinical trial is for adults who have struggled with moderate to severe Atopic Dermatitis for at least six months and have seen little or no improvement with current treatments.

The study is testing two investigational medications that use antibodies to target proteins believed to play a role in inflammatory skin conditions like eczema. The medications are given by a medical provider through subcutaneous injections given either every 2 weeks or every 4 weeks, depending on the study group.

The study will last up to 40 or 56 weeks, depending on the group assigned. Participation is at no cost and includes all study-related exams, skin assessments, lab work, ECGs, genetic testing, and other evaluations. Reimbursement for travel may also be available.